Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension

Show simple item record Khanna, Dinesh en_US Gladue, Heather en_US Channick, Richard en_US Chung, Lorinda en_US Distler, Oliver en_US Furst, Daniel E. en_US Hachulla, Eric en_US Humbert, Marc en_US Langleben, David en_US Mathai, Stephen C. en_US Saggar, Rajeev en_US Visovatti, Scott en_US Altorok, Nezam en_US Townsend, Whitney en_US FitzGerald, John en_US McLaughlin, Vallerie V. en_US 2013-12-04T18:57:18Z 2015-01-05T13:54:43Z en_US 2013-12 en_US
dc.identifier.citation Khanna, Dinesh; Gladue, Heather; Channick, Richard; Chung, Lorinda; Distler, Oliver; Furst, Daniel E.; Hachulla, Eric; Humbert, Marc; Langleben, David; Mathai, Stephen C.; Saggar, Rajeev; Visovatti, Scott; Altorok, Nezam; Townsend, Whitney; FitzGerald, John; McLaughlin, Vallerie V. (2013). "Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension." Arthritis & Rheumatism 65(12): 3194-3201. en_US
dc.identifier.issn 0004-3591 en_US
dc.identifier.issn 1529-0131 en_US
dc.publisher RAND Corporation en_US
dc.publisher Wiley Periodicals, Inc. en_US
dc.title Recommendations for Screening and Detection of Connective Tissue Disease–Associated Pulmonary Arterial Hypertension en_US
dc.type Article en_US
dc.rights.robots IndexNoFollow en_US
dc.subject.hlbsecondlevel Geriatrics en_US
dc.subject.hlbtoplevel Health Sciences en_US
dc.description.peerreviewed Peer Reviewed en_US
dc.identifier.doi 10.1002/art.38172 en_US
dc.identifier.source Arthritis & Rheumatism en_US
dc.identifier.citedreference Bae S, Saggar R, Bolster MB, Chung L, Csuka ME, Derk C, et al, for the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Investigators. Baseline characteristics and follow‐up in patients with normal haemodynamics versus borderline mean pulmonary arterial pressure in systemic sclerosis—results from the PHAROS registry. Ann Rheum Dis 2012; 71: 1335 – 42. en_US
dc.identifier.citedreference Alarcon‐Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp G, editors. Mixed connective tissue disease and anti‐nuclear antibodies. Amsterdam: Elsevier; 1987. p. 33 – 40. en_US
dc.identifier.citedreference Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease—an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972; 52: 148 – 59. en_US
dc.identifier.citedreference Kahn MF, Appelboom T. Syndrom de Sharp. In: Kahn MF, Peltier AP, Meyer O, Piette JC, editors. Les maladies systemiques. 3rd ed. Paris: Flammarion; 1991. p. 545 – 556. en_US
dc.identifier.citedreference Kasukawa R, Tojo T, Miyawaki S. Preliminary diagnostic criteria for classification of mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed connective tissue disease and anti‐nuclear antibodies. Amsterdam: Elsevier; 1987. p. 41 – 8. en_US
dc.identifier.citedreference Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, et al, and the ItinerAIR‐Sclerodermie Study Group. The three‐year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France. Arthritis Rheum 2009; 60: 1831 – 9. en_US
dc.identifier.citedreference Yoshida S. Pulmonary arterial hypertension in connective tissue diseases. Allergol Int 2011; 60: 405 – 9. en_US
dc.identifier.citedreference Hoeper MM. Definition, classification, and epidemiology of pulmonary arterial hypertension. Semin Respir Crit Care Med 2009; 30: 369 – 75. en_US
dc.identifier.citedreference Tunariu N, Gibbs SJ, Win Z, Gin‐Sing W, Graham A, Gishen P, et al. Ventilation‐perfusion scintigraphy is more sensitive than multidetector CTPA in detecting chronic thromboembolic pulmonary disease as a treatable cause of pulmonary hypertension. J Nucl Med 2007; 48: 680 – 4. en_US
dc.identifier.citedreference Coghlan JG, Denton CP, Grunig E, Bonderman D, Distler O, Khanna D, et al, on behalf of the DETECT Study Group. Evidence‐based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann Rheum Dis 2013. E‐pub ahead of print. en_US
dc.identifier.citedreference Montani D, Savale L, Natali D, Jais X, Herve P, Garcia G, et al. Long‐term response to calcium‐channel blockers in non‐idiopathic pulmonary arterial hypertension. Eur Heart J 2010; 31: 1898 – 907. en_US
dc.identifier.citedreference Saggar R, Khanna D, Furst DE, Shapiro S, Maranian P, Belperio JA, et al. Exercise‐induced pulmonary hypertension associated with systemic sclerosis: four distinct entities. Arthritis Rheum 2010; 62: 3741 – 50. en_US
dc.identifier.citedreference Walker UA, Tyndall A, Czirjak L, Denton C, Farge‐Bancel D, Kowal‐Bielecka O, et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754 – 63. en_US
dc.identifier.citedreference Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjögren's syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore) 2007; 86: 299 – 315. en_US
dc.identifier.citedreference Humbert M, Gerry Coghlan J, Khanna D. Early detection and management of pulmonary arterial hypertension. Eur Respir Rev 2012; 21: 306 – 12. en_US
dc.identifier.citedreference The Criteria Committee of the New York Heart Association. Nomenclature and Criteria for Diagnosis of Diseases of the Heart and Great Vessels. 9th ed. Boston: Little Brown; 1994. p. 253 – 6. en_US
dc.identifier.citedreference Rajaram S, Swift AJ, Capener D, Elliot CA, Condliffe R, Davies C, et al. Comparison of the diagnostic utility of cardiac magnetic resonance imaging, computed tomography, and echocardiography in assessment of suspected pulmonary arterial hypertension in patients with connective tissue disease. J Rheumatol 2012; 39: 1265 – 74. en_US
dc.identifier.citedreference Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29: 515 – 24. en_US
dc.identifier.citedreference Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, et al. High N‐terminal pro–brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis. Arthritis Rheum 2008; 58: 284 – 91. en_US
dc.identifier.citedreference Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, et al. N‐terminal pro‐brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case‐control study. Arthritis Res Ther 2012; 14: R143. en_US
dc.identifier.citedreference Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, et al. Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study. Arthritis Rheum 2005; 52: 3792 – 800. en_US
dc.identifier.citedreference Meune C, Avouac J, Airo P, Beretta L, Dieude P, Wahbi K, et al. Prediction of pulmonary hypertension related to systemic sclerosis by an index based on simple clinical observations. Arthritis Rheum 2011; 63: 2790 – 6. en_US
dc.identifier.citedreference Gladue H, Steen V, Allanore Y, Saggar R, Saggar R, Maranian P, et al. Combination of echocardiographic and pulmonary function test measures improves sensitivity for the diagnosis of systemic sclerosis‐associated pulmonary arterial hypertension: analysis of two cohorts. J Rheumatol 2013. E‐pub 8/21/13. en_US
dc.identifier.citedreference Phung S, Strange G, Chung LP, Leong J, Dalton B, Roddy J, et al. Prevalence of pulmonary arterial hypertension in an Australian scleroderma population: screening allows for earlier diagnosis. Intern Med J 2009; 39: 682 – 91. en_US
dc.identifier.citedreference Ciurzynski M, Bienias P, Irzyk K, Rymarczyk Z, Kostrubiec M, Lichodziejewska B, et al. Accuracy of Doppler echocardiography in the hemodynamic assessment of pulmonary hypertension in patients with systemic sclerosis. Eur Heart J 2010; 31: 869 – 70. en_US
dc.identifier.citedreference Jansa P, Becvar R, Ambroz D, Palecek T, Tomcik M, Skacelova S, et al. Pulmonary arterial hypertension associated with systemic sclerosis in the Czech Republic. Clin Rheumatol 2012; 31: 557 – 61. en_US
dc.identifier.citedreference Avouac J, Airo P, Meune C, Beretta L, Dieude P, Caramaschi P, et al. Prevalence of pulmonary hypertension in systemic sclerosis in European Caucasians and metaanalysis of 5 studies. J Rheumatol 2010; 37: 2290 – 8. en_US
dc.identifier.citedreference Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010; 23: 685 – 713. en_US
dc.identifier.citedreference Nair R, Aggarwal R, Khanna D. Methods of formal consensus in classification/diagnostic criteria and guideline development. Semin Arthritis Rheum 2011; 41: 95 – 105. en_US
dc.identifier.citedreference Singh JA, Furst DE, Bharat A, Curtis JR, Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken) 2012; 64: 625 – 39. en_US
dc.identifier.citedreference Mukerjee D, St George D, Knight C, Davar J, Wells AU, Du Bois RM, et al. Echocardiography and pulmonary function as screening tests for pulmonary arterial hypertension in systemic sclerosis. Rheumatology (Oxford) 2004; 43: 461 – 6. en_US
dc.identifier.citedreference Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, et al. Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long‐term survival. Arthritis Rheum 2011; 63: 3522 – 30. en_US
dc.identifier.citedreference Burdt MA, Hoffman RW, Deutscher SL, Wang GS, Johnson JC, Sharp GC. Long‐term outcome in mixed connective tissue disease: longitudinal clinical and serologic findings. Arthritis Rheum 1999; 42: 899 – 909. en_US
dc.identifier.citedreference Ruiz‐Irastorza G, Garmendia M, Villar I, Egurbide MV, Aguirre C. Pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy. Autoimmun Rev 2013; 12: 410 – 5. en_US
dc.identifier.citedreference Udayakumar N, Venkatesan S, Rajendiran C. Pulmonary hypertension in rheumatoid arthritis–relation with the duration of the disease. Int J Cardiol 2008; 127: 410 – 2. en_US
dc.identifier.citedreference Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F, et al. Connective tissue disease‐associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 2009; 179: 151 – 7. en_US
dc.identifier.citedreference McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, et al. ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53: 1573 – 619. en_US
dc.identifier.citedreference Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al, Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 2009; 34: 1219 – 63. en_US
dc.identifier.citedreference Badesch DB, Champion HC, Sanchez MA, Hoeper MM, Loyd JE, Manes A, et al. Diagnosis and assessment of pulmonary arterial hypertension. J Am Coll Cardiol 2009; 54: S55 – 66. en_US
dc.identifier.citedreference Fitch K, Bernstein SJ, Aguilar MS, Burnand B, LaCalle JR, Lazaro P, et al. The RAND/UCLA appropriateness method user's manual. Santa Monica (CA): RAND Corporation; 2001. en_US
dc.identifier.citedreference Khanna D, Khanna PP, FitzGerald JD, Singh MK, Bae S, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 2. Therapy and antiinflammatory prophylaxis of acute gouty arthritis. Arthritis Care Res (Hoboken) 2012; 64: 1447 – 61. en_US
dc.identifier.citedreference Khanna D, FitzGerald JD, Khanna PP, Bae S, Singh MK, Neogi T, et al. 2012 American College of Rheumatology guidelines for management of gout. Part 1. Systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia. Arthritis Care Res (Hoboken) 2012; 64: 1431 – 46. en_US
dc.identifier.citedreference Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, et al. American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis [published erratum appears in Arthritis Care Res (Hoboken) 2012;64:464]. Arthritis Care Res (Hoboken) 2010; 62: 1515 – 26. en_US
dc.identifier.citedreference Saag KG, Teng GG, Patkar NM, Anuntiyo J, Finney C, Curtis JR, et al. American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis. Arthritis Rheum 2008; 59: 762 – 84. en_US
dc.identifier.citedreference Gladue H, Altorok N, Townsend W, McLaughlin V, Khanna D. Screening and diagnostic modalities for connective tissue disease‐associated pulmonary arterial hypertension: a systematic review. Semin Arthritis Rheum 2013. E‐pub 9/10/13. en_US
dc.identifier.citedreference Whiting P, Rutjes AW, Reitsma JB, Bossuyt PM, Kleijnen J. The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol 2003; 3: 25. en_US
dc.identifier.citedreference Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB, et al. QUADAS‐2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011; 155: 529 – 36. en_US
dc.identifier.citedreference Atkins D, Best D, Briss PA, Eccles M, Falck‐Ytter Y, Flottorp S, et al, GRADE Working Group. Grading quality of evidence and strength of recommendations. BMJ 2004; 328: 1490. en_US
dc.identifier.citedreference Schunemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al, GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008; 336: 1106 – 10. en_US
dc.identifier.citedreference National Conference on chronic disease. Public Health Nurs 1951; 43: 344. en_US
dc.identifier.citedreference Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23: 581 – 90. en_US
dc.owningcollname Interdisciplinary and Peer-Reviewed
 Show simple item record

This item appears in the following Collection(s)

Search Deep Blue

Advanced Search

Browse by

My Account


Available Now

MLibrary logo